Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £1,857 | £2,670 | £2,217 | £1,818 |
| % Growth | -30.4% | 20.4% | 21.9% | – |
| Cost of Goods Sold | £1,947 | £2,612 | £1,605 | £1,938 |
| Gross Profit | -£90 | £58 | £612 | -£12,622,910 |
| % Margin | -4.8% | 2.2% | 27.6% | -694,329.5% |
| R&D Expenses | £0 | £303 | £0 | £637 |
| G&A Expenses | £0 | £353 | £1,481 | £572 |
| SG&A Expenses | £1,532 | £705 | £1,481 | £572 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£303 | £837 | £130 |
| Operating Expenses | £1,532 | £705 | £2,318 | £1,338 |
| Operating Income | -£1,622 | -£647 | -£1,706 | -£1,458 |
| % Margin | -87.3% | -24.2% | -77% | -80.2% |
| Other Income/Exp. Net | -£450 | -£452 | -£442 | -£413 |
| Pre-Tax Income | -£2,072 | -£1,099 | -£2,148 | -£1,871 |
| Tax Expense | £68 | £94 | £65 | -£6 |
| Net Income | -£2,140 | -£1,193 | -£2,213 | -£1,865 |
| % Margin | -115.2% | -44.7% | -99.8% | -102.6% |
| EPS | -0.007 | -0.004 | -0.008 | -0.006 |
| % Growth | -80% | 46.7% | -19% | – |
| EPS Diluted | -0.007 | -0.004 | -0.008 | -0.006 |
| Weighted Avg Shares Out | 295,182 | 298,250 | 295,106 | 295,188 |
| Weighted Avg Shares Out Dil | 295,182 | 298,250 | 295,182 | 295,182 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £450 | £452 | £442 | £413 |
| Depreciation & Amortization | £414 | £407 | £430 | £196 |
| EBITDA | -£1,208 | -£240 | -£1,276 | -£1,262 |
| % Margin | -65.1% | -9% | -57.6% | -69.4% |